Clinical Trials in Egypt / NCT07245550
Starting soon
Observational
Thyroid and Adrenal Disorders in ICU
NCT07245550 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Septic Shock
Investigational drug(s) / intervention(s)
Blood sampling
Blood sampling: Blood sampling for the hormones
Study summary
A dysregulated host response to infection results in organ failure and sepsis, a potentially fatal illness. Sepsis killed about 11 million people worldwide in 2017 and had a death rate close to 20 %
Eligibility
Inclusion criteria
* All Patients who match the diagnostic criteria for sepsis/septic shock as stated
* admitted in ICU
Exclusion Criteria:
1. Patients refuse to be enrolled in the study
2. Patients with previous endocrinal disorders.
3. Patients receiving corticosteroid or thyroid hormonal therapy.
4. Pregnancy or lactation.
5. Previous endocrinal gland surgery.
6. Individuals with pacing rhythms, bundle branch blocks (QRS interval \>120 ms),
Primary outcome measure(s)
- serum Thyroid and adrenal hormones levels — 24 hours
measurement of thyroid and adrenal hormones (TSH-FT3-FT4 - cortisol level ) will be measured by ELLISA technique in septic shock patients at ICU.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Radwa mahmoud | Asyut | Egypt |
More Assiut University trials in Egypt
The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion
Starting soon
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores
Starting soon
Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH
Starting soon
Intraoperative Lidocaine Infusion
Starting soon
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07245550 on ClinicalTrials.gov ↗ ← All trials in Egypt